Literature DB >> 10878494

Binding of glucocorticoids to human nasal tissue in vitro.

N Esmailpour1, P Högger, P Rohdewald.   

Abstract

BACKGROUND: Intranasal application of glucocorticoids is an efficacious treatment of allergic rhinitis and some cases of nonallergic rhinitis. However, no data on binding of glucocorticoids to nasal tissue are available. Pronounced binding of the compound to the target tissue is favorable as it might serve as a local deposit delivering the glucocorticoid to specific receptors and it slows down the efflux of the compound into systemic circulation.
METHODS: Human nasal tissue was incubated with fluticasone propionate, budesonide, flunisolide and beclomethasone-17-monopropionate. Kinetics of binding and redistribution of the tissue-bound fraction into human plasma was monitored.
RESULTS: Binding of glucocorticoids to human nasal tissue was fast and highest for the lipophilic fluticasone propionate, followed by beclomethasone-17-monopropionate. Also, highest concentrations of these lipophilic glucocorticoids remained in nasal tissue after equilibration of drug-saturated tissue with plasma.
CONCLUSIONS: Lipophilic compounds exhibit a high tissue binding and retention which is an important property of topically applied glucocorticoids. It is the basis for prolonged action and low concentration of the compound in systemic circulation. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878494     DOI: 10.1159/000024371

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

Review 1.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Metabolism of ciclesonide in the upper and lower airways: review of available data.

Authors:  Ruediger Nave; Nigel McCracken
Journal:  J Asthma Allergy       Date:  2008-09-07

Review 3.  Mometasone furoate nasal spray: a review of safety and systemic effects.

Authors:  Myron Zitt; Teddy Kosoglou; James Hubbell
Journal:  Drug Saf       Date:  2007       Impact factor: 5.228

4.  Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.

Authors:  Alberto Papi; Adel H Mansur; Tetyana Pertseva; Kirsten Kaiser; Tammy McIver; Birgit Grothe; Sanjeeva Dissanayake
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-04-22       Impact factor: 2.849

5.  Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa.

Authors:  Hideyuki Sato; Ruediger Nave; Takashi Nonaka; Nishibe Yoshihisa; Nagano Atsuhiro; Tsutomu Mochizuki; Shigehiro Takahama; Shiro Kondo; Mark Wingertzahn
Journal:  BMC Pharmacol       Date:  2007-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.